INTEGRA F- ferrous fumarate and polysacchride iron complex and folic acid capsule

Țară: Statele Unite ale Americii

Limbă: engleză

Sursă: NLM (National Library of Medicine)

Ingredient activ:

FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR), FERROUS ASPARTO GLYCINATE (UNII: H7426RGB3L) (FERROUS CATION - UNII:GW89581OWR), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8), ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), NIACIN (UNII: 2679MF687A) (NIACIN - UNII:2679MF687A)

Disponibil de la:

U.S. Pharmaceutical Corporation

INN (nume internaţional):

FERROUS FUMARATE

Compoziție:

FERROUS FUMARATE 191.2 mg

Calea de administrare:

ORAL

Tip de prescriptie medicala:

PRESCRIPTION DRUG

Indicații terapeutice:

DESCRIPTION: Each capsule contains: Ferrous Fumarate (anhydrous) ..................................191.1 mg Polysaccharide Iron Complex..................................... 135.9 mg (Equivalent to about 125 mg of elemental iron) Folic Acid ....................................................................................1 mg Ascorbic Acid (from ProAscorb C‡) ................................ 40 mg Vitamin B3 (from ProAscorb C‡) ........................................3 mg CLINICAL PHARMACOLOGY: Integra FTM is unique in that it utilizes two (2) different forms of iron, i.e., Ferrous Fumarate and Polysaccharide Iron Complex (as cell-contracted akaganèite), making available a total of 125 mg of elemental iron per capsule as follows: Ferrous Fumarate (anhydrous)    191.1 mg Polysaccharide iron complex (PIC)    135.9 mg Ferrous Fumarate: Provides about 62.5 mg of elemental iron per dose. Ferrous Fumarate is an anhydrous salt of a combination of ferrous iron and fumaric acid, containing 33% of iron per weight.

Statutul autorizaţiei:

unapproved drug other

Caracteristicilor produsului

INTEGRA F - FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC
ACID CAPSULE
U.S. PHARMACEUTICAL CORPORATION
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
SEE ALL PRESCRIBING INFORMATION FOR INTEGRA F
DESCRIPTION: Each capsule contains: Ferrous Fumarate (anhydrous)
..................................191.1 mg Polysaccharide Iron
Complex.....................................
135.9 mg (Equivalent to about 125 mg of elemental iron) Folic Acid
....................................................................................1
mg Ascorbic Acid (from
ProAscorb C‡) ................................ 40 mg Vitamin B3
(from ProAscorb C‡)
........................................3 mg
CLINICAL PHARMACOLOGY: Integra FTM is unique in that it utilizes two
(2) different
forms of iron, i.e., Ferrous Fumarate and Polysaccharide Iron Complex
(as cell-
contracted akaganè
ite), making available a total of 125 mg of elemental iron per capsule
as follows:
Ferrous Fumarate (anhydrous) 191.1 mg Polysaccharide iron complex
(PIC) 135.9
mg
Ferrous Fumarate: Provides about 62.5 mg of elemental iron per dose.
Ferrous
Fumarate is an anhydrous salt of a combination of ferrous iron and
fumaric acid,
containing 33% of iron per weight. The acute toxicity in experimental
animals is low and
Ferrous Fumarate is well tolerated clinically. As a ferrous salt, it
is more efficiently
absorbed in the duodenum. Ferrous Fumarate contrasts very favorably
with the
availability of the 20% of elemental iron of ferrous sulfate, and the
13% of elemental iron
of ferrous gluconate.
Polysaccharide Iron Complex: Provides about 62.5 mg elemental iron, as
a cell-
contracted akaganè
ite. It is a product of ferric iron complexed to a low molecular
weight
polysaccharide. This polysaccharide is produced by the extensive
hydrolysis of starch
and is a dark brown powder that dissolves in water to form a very dark
br